The assistive gait devices and their implementation in activities of daily living for patients with neuromuscular disease: A systematic review and meta-analysis
Journal of Neuromuscular Diseases · 2026
DOI: 10.1177/22143602241289216 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neuromuscular Diseases, 2026. Verfasst von Marko Mijic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität Munich, Germany. Hauptthemen laut MEDLINE: Neuromuscular Diseases, Activities of Daily Living, Self-Help Devices, Exoskeleton Device. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
To date, assistive gait devices (AGDs) for people with neuromuscular diseases (NMDs) have not been systematically evaluated.
Objective
This systematic review evaluated AGDs for people with NMDs.
Methods
Suitable tools were used to assess the study quality and the certainty of evidence. If feasible, a descriptive and quantitative synthesis was conducted.
Results
Forty studies were included on: gait-assisting exoskeletons (GAEs), orthopaedic footwear (OF), knee and/or ankle-foot-orthoses (AFOs) and non-invasive neuroprostheses that provide functional electrical stimulation (FES). Pairwise meta-analysis could not be performed due to a lack of homogenous data. The within-group pre-post meta-analysis in GAE studies showed an improvement in 2-min walk test (2MWT) (m) (standardized mean difference [SMD] = 0.36, 95%-CI: 0.17 to 0.54), but not in 10-meter walk test (10MWT) (sec) (SMD = 0.33, 95%-CI: −0.10 to 0.76) and in functional independence measure (FIM) (SMD = −0.002, 95%-CI: −0.21 to 0.21). In AFO studies, there was no improvement in 10MWT(m) (SMD = −0.11, 95%-CI: −0.76 to 0.53). A single session with AFO or OF vs no-AFO or OF post-intervention meta-analysis did not reveal an improvement in walking speed (m/s) (SMD = 0.39, 95%-CI: −0.03 to 0.83).
Discussion
GAEs seem to help patients to walk longer. The meta-analyses showed no significant results to support the effect of AFOs or OF. Neuroprostheses and knee orthoses showed no evidence.
Conclusion
No clear conclusions can be drawn on how AGDs affect NMDs. The positive AGD effects are based on very low certainty of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität Munich, Germany.
- Department of Sport Science and Sport, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
- Clinic for Neurology, Medical Park, Reithof Park, Bad Feilnbach, Germany.
ORCID-Profile: Marko Mijic, Andres Jung, Benedikt Schoser
Zitieren
APA
Mijic, M., Wirner-Piotrowski, C., Jung, A., Gutschmidt, K., Arndt, M., García-Angarita, N., Wenninger, S., Young, P., & Schoser, B. (2026). The assistive gait devices and their implementation in activities of daily living for patients with neuromuscular disease: A systematic review and meta-analysis. Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602241289216
Vancouver
Mijic M, Wirner-Piotrowski C, Jung A, Gutschmidt K, Arndt M, García-Angarita N, et al. The assistive gait devices and their implementation in activities of daily living for patients with neuromuscular disease: A systematic review and meta-analysis. Journal of Neuromuscular Diseases. 2026. doi:10.1177/22143602241289216
BibTeX
@article{Mijic2026,
author = {Mijic, Marko and Wirner-Piotrowski, Corinna and Jung, Andres and Gutschmidt, Kristina and Arndt, Marcela and García-Angarita, Natalia and Wenninger, Stephan and Young, Peter and Schoser, Benedikt},
title = {The assistive gait devices and their implementation in activities of daily living for patients with neuromuscular disease: A systematic review and meta-analysis},
journal = {Journal of Neuromuscular Diseases},
year = {2026},
doi = {10.1177/22143602241289216}
}
EUVIMED